Squarepoint Ops LLC Ardelyx, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 35,132 shares of ARDX stock, worth $185,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,132
Previous 460,689 92.37%
Holding current value
$185,145
Previous $3.41 Million 92.91%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.28 - $7.57 $2.25 Million - $3.22 Million
-425,557 Reduced 92.37%
35,132 $242,000
Q2 2024

Aug 14, 2024
BUY
$5.89 - $9.31 $2.14 Million - $3.39 Million
363,894 Added 375.94%
460,689 $3.41 Million
Q1 2024

May 15, 2024
SELL
$6.05 - $9.74 $1.39 Million - $2.24 Million
-229,494 Reduced 70.33%
96,795 $706,000
Q4 2023

Feb 14, 2024
BUY
$3.29 - $6.64 $1.07 Million - $2.17 Million
326,289 New
326,289 $2.02 Million
Q1 2023

May 15, 2023
BUY
$2.68 - $4.79 $679,983 - $1.22 Million
253,725 New
253,725 $1.22 Million
Q2 2022

Aug 15, 2022
BUY
$0.51 - $1.17 $5,795 - $13,295
11,364 New
11,364 $7,000
Q4 2021

Feb 14, 2022
SELL
$0.86 - $1.7 $18,728 - $37,020
-21,777 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.27 - $8.17 $27,656 - $177,918
21,777 New
21,777 $29,000
Q1 2021

May 17, 2021
SELL
$6.1 - $7.69 $515,175 - $649,458
-84,455 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$5.05 - $7.1 $30,426 - $42,777
-6,025 Reduced 6.66%
84,455 $546,000
Q3 2020

Nov 16, 2020
SELL
$5.25 - $7.08 $21,063 - $28,404
-4,012 Reduced 4.25%
90,480 $475,000
Q2 2020

Aug 14, 2020
SELL
$5.37 - $8.11 $142,122 - $214,639
-26,466 Reduced 21.88%
94,492 $654,000
Q1 2020

May 15, 2020
SELL
$4.35 - $8.79 $605,489 - $1.22 Million
-139,193 Reduced 53.5%
120,958 $688,000
Q4 2019

Feb 14, 2020
BUY
$4.23 - $8.29 $1.03 Million - $2.01 Million
242,965 Added 1413.74%
260,151 $1.95 Million
Q3 2019

Nov 14, 2019
SELL
$2.15 - $6.28 $80,068 - $233,873
-37,241 Reduced 68.42%
17,186 $81,000
Q2 2019

Aug 14, 2019
SELL
$2.49 - $3.73 $532,095 - $797,074
-213,693 Reduced 79.7%
54,427 $146,000
Q1 2019

May 15, 2019
SELL
$1.88 - $3.35 $12,919 - $23,021
-6,872 Reduced 2.5%
268,120 $751,000
Q4 2018

Feb 14, 2019
BUY
$1.66 - $4.16 $164,530 - $412,318
99,115 Added 56.35%
274,992 $492,000
Q3 2018

Nov 14, 2018
BUY
$3.75 - $4.65 $517,788 - $642,058
138,077 Added 365.28%
175,877 $765,000
Q2 2018

Aug 14, 2018
BUY
$3.7 - $5.8 $139,860 - $219,240
37,800 New
37,800 $140,000
Q1 2018

May 15, 2018
SELL
$5.05 - $7.9 $99,631 - $155,859
-19,729 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$4.85 - $7.8 $95,685 - $153,886
19,729
19,729 $130,000

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email